Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dennis Ledford

Allergy & Immunology Tampa, FL Medical Doctor

NPI 1376528042 CMS profile 61521

13801 Bruce B Downs Blvd, Suite 502, Tampa, FL 33613

Open in the dashboard

General payments

$1,186,289

1,201 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$196,558 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Dennis Ledford of Tampa, FL is reported in the CMS Open Payments database as having received $1,186,289 across 1,201 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $196,558 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $189,798 169
2024 General $172,744 169
2023 General $206,789 206
2022 General $189,495 157
2021 General $120,677 98
2020 General $89,372 116
2019 General $217,415 286

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dennis Ledford
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Dennis Ledford were reported at $189,798. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year Dennis Ledford Allergy & Immunology median Middle half National median
2019 $217,415 $594 $163–$1,512 $163
2020 $89,372 $426 $106–$1,233 $114
2021 $120,677 $638 $157–$1,708 $132
2022 $189,495 $790 $205–$1,961 $149
2023 $206,789 $852 $220–$2,147 $160
2024 $172,744 $865 $203–$2,267 $164
2025 $189,798 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $364,434 376 payments
  2. GlaxoSmithKline, LLC. $337,891 299 payments
  3. Genzyme Corporation $190,837 143 payments
  4. Regeneron Healthcare Solutions, Inc. $125,822 134 payments
  5. Genentech USA, Inc. $71,614 74 payments
  6. Novartis Pharmaceuticals Corporation $22,209 39 payments
  7. Amgen Inc. $21,799 19 payments
  8. ALK-Abello, Inc $16,553 19 payments
  9. CSL Behring $13,141 27 payments
  10. BioCryst Pharmaceuticals, Inc. $8,484 9 payments
  11. Other $13,506 62 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $940,666 339 payments
  2. Travel and Lodging $120,350 365 payments
  3. Consulting Fee $90,833 27 payments
  4. Food and Beverage $30,215 462 payments
  5. Honoraria $4,080 2 payments
  6. Education $144 6 payments
Products named General payments · program years 2019–2025
  1. NUCALA Immunology $234,975 202 payments
  2. DUPIXENT Immunology $138,458 103 payments
  3. AIRSUPRA $113,912 115 payments
  4. DUPIXENT Inflammation And Immunology $102,770 120 payments
  5. TEZSPIRE Respiratory $92,764 73 payments
  6. FASENRA Respiratory $86,009 89 payments
  7. NUCALA Respiratory $82,999 81 payments
  8. FASENRA Respiratory $52,025 65 payments
  9. Xolair $49,036 54 payments
  10. TEZSPIRE Inflammation $17,647 16 payments
  11. Other $82,505 158 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,201 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record